TheEdgeResearch
Home / Stocks / THCBF

THC Biomed Intl Ltd. (THCBF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$205,015
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.36
52-Wk Range
0.001-0.0245
CEO
John Miller
Country
CA
Currency
USD

THC Biomed Intl Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Kelowna, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $205,015. On trailing twelve-month figures it carries a trailing P/E of -1.07, a net margin of -91.8%. Its beta of -0.36 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.07
Price / Sales
0.98
Price / Book
0.47
EV / EBITDA
-4.45
Gross margin
-30.8%
Operating margin
-95.9%
Net margin
-91.8%
Return on equity
Debt / equity
0.65
Current ratio
0.63
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
35
IPO date
2018-03-16
Headquarters
Kelowna, BC, CA
About THC Biomed Intl Ltd.

THC Biomed Intl Ltd. is a Canadian enterprise engaged in the production and sale of cannabis products for both medical and recreational consumers. Its offerings encompass a range of cannabis-infused edibles and drinks, such as beverage shots, gummies, and biscuits marketed under the THC KISS label, in addition to standalone pure cannabis sticks. This company was established in 2012 and operates from its headquarters in Kelowna, Canada.

Comparable companies

THC Biomed Intl Ltd. is most often compared with the following Healthcare names:

AVTBFBBRRFBUDZCANNCPIVFMVMDFPCLOFRPNRFRVVQFVDQSF
More research on THCBF
THCBF technical analysis THCBF TheEdge Score Compare against peers
Open full interactive analysis & DCF →